EDGAR Filing Documents for 0001649094-24-000016

Form 4 - Statement of changes in beneficial ownership of securities:

SEC Accession No. 0001649094-24-000016

Filing Date

2024-06-10

Accepted

2024-06-10 16:13:38

Documents

Period of Report

2024-06-07

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 4	wk-form4_1718050409.html	4
1	FORM 4	wk-form4_1718050409.xml	4	3469
2	EX-24	poasection16filings-eyde.htm	EX-24	4121
3		poasection16filings-eyde001.jpg	GRAPHIC	248859
	Complete submission text file	0001649094-24-000016.txt		352010

Mailing Address 825 INDUSTRIAL ROAD, STE. 300 SAN CARLOS CA 94070

Business Address 825 INDUSTRIAL ROAD, STE. 300 SAN CARLOS CA 94070 650-837-0111

Vaxcyte, Inc. (Issuer) CIK: 0001649094 (see all company filings)

IRS No.: 464233385 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O VAXCYTE, INC. 825 INDUSTRIAL ROAD, SUITE 300 SAN CARLOS CA 94070

Business Address

Eydelman Mikhail (Reporting) CIK: 0001918033 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39323 | Film No.: 241032841